WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032196) SECRETIN FRAGMENTS FOR TREATING AUTISM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032196    International Application No.:    PCT/EP2000/010847
Publication Date: 10.05.2001 International Filing Date: 03.11.2000
IPC:
A61K 38/00 (2006.01), C07K 14/645 (2006.01)
Applicants: GOLDHAM PHARMA GMBH [DE/DE]; Am Wasserberg 11, 86441 Zusmarshausen (DE) (For All Designated States Except US).
FRANK, Artur [DE/DE]; (DE) (For US Only).
JORDAN, Karl [DE/DE]; (DE) (For US Only).
HIEBL, Wilfried [DE/DE]; (DE) (For US Only)
Inventors: FRANK, Artur; (DE).
JORDAN, Karl; (DE).
HIEBL, Wilfried; (DE)
Agent: WIBBELMANN, Jobst; Wuesthoff & Wuesthoff, Schweigerstrasse 2, 81541 München (DE)
Priority Data:
199 53 339.3 05.11.1999 DE
Title (DE) SECRETINFRAGMENTE ZUR BEHANDLUNG VON AUTISMUS
(EN) SECRETIN FRAGMENTS FOR TREATING AUTISM
(FR) FRAGMENTS DE SECRETINE DESTINES AU TRAITEMENT DE L'AUTISME
Abstract: front page image
(DE)Es werden pharmazeutische Zusammensetzungen enthaltend bestimmte Secretinfragmente beschrieben, die sich besonders zur Diagnostik und Behandlung von Autismus eignen. Bevorzugt sind pharmazeutische Zusammensetzungen enthaltend mindestens ein Peptid der folgenden Formel: His-Ser-Asp-Gly-Thr-Phe-Thr-Ser (A), His-Ser-Asp-Gly-Thr-Phe-Thr (B), His-Ser-Asp-Gly-Thr-Phe (C), His-Ser-Asp-Gly-Thr (D), His-Ser-Asp-Gly-(E), Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val (F), Arg-Leu-Leu-Gln-Gly-Leu-Val (G), Leu-Leu-Gln-Gly-Leu-Val (H), Leu-Gln-Gly-Leu-Val (I) und Gln-Gly-Leu-Val (J).
(EN)The invention relates to pharmaceutical compositions containing certain secretin fragments that are particularly suitable for diagnosing and treating autism. Said pharmaceutical compositions preferably contain at least one of the peptides of formulae: His-Ser-Asp-Gly-Thr-Phe-Thr-Ser (A), His-Ser-Asp-Gly-Thr-Phe-Thr (B), His-Ser-Asp-Gly-Thr-Phe (C), His-Ser-Asp-Gly-Thr (D), His-Ser-Asp-Gly-(E), Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val (F), Arg-Leu-Leu-Gln-Gly-Leu-Val (G), Leu-Leu-Gln-Gly-Leu-Val (H), Leu-Gln-Gly-Leu-Val (I) and Gln-Gly-Leu-Val (J).
(FR)L'invention concerne des compositions pharmaceutiques contenant certains fragments de sécrétine particulièrement adaptés au diagnostic et au traitement de l'autisme. On préfère les compositions pharmaceutiques contenant au moins un peptide de la formule suivante: His-Ser-Asp-Gly-Thr-Phe-Thr-Ser (A), His-Ser-Asp-Gly-Thr-Phe-Thr (B), His-Ser-Asp-Gly-Thr-Phe (C), His-Ser-Asp-Gly-Thr (D), His-Ser-Asp-Gly-(E), Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val (F), Arg-Leu-Leu-Gln-Gly-Leu-Val (G), Leu-Leu-Gln-Gly-Leu-Val (H), Leu-Gln-Gly-Leu-Val (I) et Gln-Gly-Leu-Val (J).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)